Sera Prognostics, Inc. Class A Common Stock (SERA) is a publicly traded Healthcare sector company. As of August 24, 2026, SERA trades at $2.14 with a market cap of $84.42M and a P/E ratio of -3.19. SERA moved +0.00% today. Year to date, SERA is -27.46%; over the trailing twelve months it is -10.08%. Its 52-week range spans $1.37 to $8.73. Analyst consensus is strong buy with an average price target of $6.00. Rallies surfaces SERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sera Prognostics, Inc. Class A Common Stock (SERA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SERA moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.14 |
| Market Cap | $84.42M |
| P/E Ratio | -3.19 |
| EPS | $-0.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.73 |
| 52-Week Low | $1.37 |
| Volume | 503 |
| Avg Volume | 0 |
| Revenue (TTM) | $81.00K |
| Net Income | $-31.93M |
| Gross Margin | -102.47% |
3 analysts cover SERA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.00.